RxDoctor Payments Data

James Glazer, MD

Sports Medicine · North Conway, NHNPI 1508969817

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Bioventus LLC at 44.0% of the total. Reporting peaked in 2019 at $173 and has fallen 83.8% since, to $28 in 2025. That places this record below the midpoint for sports medicine clinicians in NH, where the typical reported total is $1,336.

$387in general payments, 2019–2025

Across 15 payments — averaging $25.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$170
  • Pacira Therapeutics, Inc.$92
  • Ferring Pharmaceuticals Inc.$67
  • Endo Pharmaceuticals Inc.$38
  • Johnson & Johnson$20

What the payments were for

  • Food & beverage$387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$387 in reported general payments places this provider in the 30th percentile of 38 sports medicine providers in New Hampshire.

See all sports medicine providers in New Hampshire

Medicare billing

Part B allowed, 2024
$143,282
Medicare patients
141
Services billed
4,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam19$156

Paid to pharmacies, not to this prescriber.

Other sports medicine in North Conway

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →